請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33539
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李財坤 | |
dc.contributor.author | Shu-Chi Lo | en |
dc.contributor.author | 羅淑祺 | zh_TW |
dc.date.accessioned | 2021-06-13T04:46:11Z | - |
dc.date.available | 2006-08-03 | |
dc.date.copyright | 2006-08-03 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-17 | |
dc.identifier.citation | Allen, D.G., Lee, J.A. and Smith, G.L. (1989) The consequences of simulated ischaemia on intracellular Ca2+ and tension in isolated ferret ventricular muscle. J Physiol, 410, 297-323.
Allen, D.G. and Orchard, C.H. (1987) Myocardial contractile function during ischemia and hypoxia. Circ Res, 60, 153-168. Andoh, T. and Ishida, R. (1998) Catalytic inhibitors of DNA topoisomerase II. Biochim Biophys Acta, 1400, 155-171. Anversa, P. and Kajstura, J. (1998) Myocyte cell death in the diseased heart. Circ Res, 82, 1231-1233. Arnold, M., Nedeltchev, K., Lyrer, P. and Baumgartner, R.W. (2003a) [Stroke prevention]. Ther Umsch, 60, 521-526. Arnold, M., Nedeltchev, K. and Mattle, H.P. (2003b) [Anticoagulation and antiaggregation in neurological patients]. Ther Umsch, 60, 33-35. Austin, C.A. and Marsh, K.L. (1998) Eukaryotic DNA topoisomerase II beta. Bioessays, 20, 215-226. Berger, J.M., Gamblin, S.J., Harrison, S.C. and Wang, J.C. (1996) Structure and mechanism of DNA topoisomerase II. Nature, 379, 225-232. Bergerat, A., de Massy, B., Gadelle, D., Varoutas, P.C., Nicolas, A. and Forterre, P. (1997) An atypical topoisomerase II from Archaea with implications for meiotic recombination. Nature, 386, 414-417. Bond, J.M., Herman, B. and Lemasters, J.J. (1991) Protection by acidotic pH against anoxia/reoxygenation injury to rat neonatal cardiac myocytes. Biochem Biophys Res Commun, 179, 798-803. Burden, D.A., Kingma, P.S., Froelich-Ammon, S.J., Bjornsti, M.A., Patchan, M.W., Thompson, R.B. and Osheroff, N. (1996) Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem, 271, 29238-29244. Capranico, G., Tinelli, S., Austin, C.A., Fisher, M.L. and Zunino, F. (1992) Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta, 1132, 43-48. Caron, P.R. and Wang, J.C. (1994) Appendix. II: Alignment of primary sequences of DNA topoisomerases. Adv Pharmacol, 29B, 271-297. Champoux, J.J. (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem, 70, 369-413. Chang, S., Hu, T. and Hsieh, T.S. (1998) Analysis of a core domain in Drosophila DNA topoisomerase II. Targeting of an antitumor agent ICRF-159. J Biol Chem, 273, 19822-19828. Chen, A.Y. and Liu, L.F. (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol, 34, 191-218. Chen, C., Ma, L., Linfert, D.R., Lai, T., Fallon, J.T., Gillam, L.D., Waters, D.D. and Tsongalis, G.J. (1997) Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol, 30, 1407-1412. Currin, R.T., Gores, G.J., Thurman, R.G. and Lemasters, J.J. (1991) Protection by acidotic pH against anoxic cell killing in perfused rat liver: evidence for a pH paradox. Faseb J, 5, 207-210. Desai, S.D., Li, T.K., Rodriguez-Bauman, A., Rubin, E.H. and Liu, L.F. (2001) Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. Cancer Res, 61, 5926-5932. Desai, S.D., Zhang, H., Rodriguez-Bauman, A., Yang, J.M., Wu, X., Gounder, M.K., Rubin, E.H. and Liu, L.F. (2003) Transcription-dependent degradation of topoisomerase I-DNA covalent complexes. Mol Cell Biol, 23, 2341-2350. Ding, D., Moskowitz, S.I., Li, R., Lee, S.B., Esteban, M., Tomaselli, K., Chan, J. and Bergold, P.J. (2000) Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp Neurol, 162, 1-12. Drake, F.H., Hofmann, G.A., Bartus, H.F., Mattern, M.R., Crooke, S.T. and Mirabelli, C.K. (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28, 8154-8160. Errington, F., Willmore, E., Tilby, M.J., Li, L., Li, G., Li, W., Baguley, B.C. and Austin, C.A. (1999) Murine transgenic cells lacking DNA topoisomerase IIbeta are resistant to acridines and mitoxantrone: analysis of cytotoxicity and cleavable complex formation. Mol Pharmacol, 56, 1309-1316. Fliss, H. and Gattinger, D. (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res, 79, 949-956. Froelich-Ammon, S.J., Burden, D.A., Patchan, M.W., Elsea, S.H., Thompson, R.B. and Osheroff, N. (1995) Increased drug affinity as the mechanistic basis for drug hypersensitivity of a mutant type II topoisomerase. J Biol Chem, 270, 28018-28021. Gadelle, D., Filee, J., Buhler, C. and Forterre, P. (2003) Phylogenomics of type II DNA topoisomerases. Bioessays, 25, 232-242. Gellert, M., Mizuuchi, K., O'Dea, M.H. and Nash, H.A. (1976) DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A, 73, 3872-3876. Gottlieb, R.A. and Engler, R.L. (1999) Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci, 874, 412-426. Grunenfelder, J., Miniati, D.N., Murata, S., Falk, V., Hoyt, E.G., Kown, M., Koransky, M.L. and Robbins, R.C. (2001) Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation, 104, I202-206. Harker, W.G., Slade, D.L., Drake, F.H. and Parr, R.L. (1991) Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform. Biochemistry, 30, 9953-9961. Harker, W.G., Slade, D.L., Parr, R.L., Feldhoff, P.W., Sullivan, D.M. and Holguin, M.H. (1995) Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res, 55, 1707-1716. Heck, M.M. and Earnshaw, W.C. (1986) Topoisomerase II: A specific marker for cell proliferation. J Cell Biol, 103, 2569-2581. Holly, T.A., Drincic, A., Byun, Y., Nakamura, S., Harris, K., Klocke, F.J. and Cryns, V.L. (1999) Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol, 31, 1709-1715. Hou, S.T. and MacManus, J.P. (2002) Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol, 221, 93-148. Hsiang, Y.H., Wu, H.Y. and Liu, L.F. (1988) Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res, 48, 3230-3235. Hu, T., Sage, H. and Hsieh, T.S. (2002) ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization. J Biol Chem, 277, 5944-5951. Imahashi, K., Schneider, M.D., Steenbergen, C. and Murphy, E. (2004) Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res, 95, 734-741. Isaacs, R.J., Davies, S.L., Sandri, M.I., Redwood, C., Wells, N.J. and Hickson, I.D. (1998) Physiological regulation of eukaryotic topoisomerase II. Biochim Biophys Acta, 1400, 121-137. Jenkins, J.R., Ayton, P., Jones, T., Davies, S.L., Simmons, D.L., Harris, A.L., Sheer, D. and Hickson, I.D. (1992) Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res, 20, 5587-5592. Jensen, L.H., Thougaard, A.V., Grauslund, M., Sokilde, B., Carstensen, E.V., Dvinge, H.K., Scudiero, D.A., Jensen, P.B., Shoemaker, R.H. and Sehested, M. (2005) Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors. Cancer Res, 65, 7470-7477. Kajstura, J., Cheng, W., Reiss, K., Clark, W.A., Sonnenblick, E.H., Krajewski, S., Reed, J.C., Olivetti, G. and Anversa, P. (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest, 74, 86-107. Kato, J., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S. and Suzuki, H. (1990) New topoisomerase essential for chromosome segregation in E. coli. Cell, 63, 393-404. Larsen, A.K., Escargueil, A.E. and Skladanowski, A. (2003) Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther, 99, 167-181. Lemasters, J.J. (1999) The mitochondrial permeability transition and the calcium, oxygen and pH paradoxes: one paradox after another. Cardiovasc Res, 44, 470-473. Lemasters, J.J., Bond, J.M., Chacon, E., Harper, I.S., Kaplan, S.H., Ohata, H., Trollinger, D.R., Herman, B. and Cascio, W.E. (1996) The pH paradox in ischemia-reperfusion injury to cardiac myocytes. Exs, 76, 99-114. Li, T.K., Chen, A.Y., Yu, C., Mao, Y., Wang, H. and Liu, L.F. (1999) Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev, 13, 1553-1560. Li, T.K. and Liu, L.F. (2001) Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol, 41, 53-77. Liu, L.F. (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem, 58, 351-375. Liu, L.F., Rowe, T.C., Yang, L., Tewey, K.M. and Chen, G.L. (1983) Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem, 258, 15365-15370. Liu, L.F. and Wang, J.C. (1987) Supercoiling of the DNA template during transcription. Proc Natl Acad Sci U S A, 84, 7024-7027. Morita, T. (1995) Low pH leads to sister-chromatid exchanges and chromosomal aberrations, and its clastogenicity is S-dependent. Mutat Res, 334, 301-308. Morita, T., Nagaki, T., Fukuda, I. and Okumura, K. (1991) Effect of pH on the activity and stability of clastogens in the in vitro chromosomal aberration test with Chinese hamster ovary K1 cells. Mutat Res, 262, 159-166. Morita, T., Nagaki, T., Fukuda, I. and Okumura, K. (1992) Clastogenicity of low pH to various cultured mammalian cells. Mutat Res, 268, 297-305. Narula, J., Haider, N., Virmani, R., DiSalvo, T.G., Kolodgie, F.D., Hajjar, R.J., Schmidt, U., Semigran, M.J., Dec, G.W. and Khaw, B.A. (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med, 335, 1182-1189. Neely, J.R. and Grotyohann, L.W. (1984) Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res, 55, 816-824. Nitiss, J.L. (1994) Roles of DNA topoisomerases in chromosomal replication and segregation. Adv Pharmacol, 29A, 103-134. Nitiss, J.L. (1998) Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta, 1400, 63-81. Nitiss, J.L., Liu, Y.X., Harbury, P., Jannatipour, M., Wasserman, R. and Wang, J.C. (1992) Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Res, 52, 4467-4472. Nitiss, J.L. and Wang, J.C. (1996) Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol, 50, 1095-1102. Ohtsubo, T., Wang, X., Takahashi, A., Ohnishi, K., Saito, H., Song, C.W. and Ohnishi, T. (1997) p53-dependent induction of WAF1 by a low-pH culture condition in human glioblastoma cells. Cancer Res, 57, 3910-3913. Opie, L.H. (1978) Myocardial metabolism and heart disease. Jpn Circ J, 42, 1223-1247. Park, H.J., Lyons, J.C., Ohtsubo, T. and Song, C.W. (1999) Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer, 80, 1892-1897. Peters, K.B. and Brown, J.M. (2002) Tirapazamine: a hypoxia-activated topoisomerase II poison. Cancer Res, 62, 5248-5253. Pommier, Y., Leteurtre, F., Fesen, M.R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G. and Kohn, K.W. (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest, 12, 530-542. Pouillart, P. (2004) Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines. Cancer Treat Rev, 30, 643-650. Pulsinelli, W.A., Waldman, S., Rawlinson, D. and Plum, F. (1982) Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology, 32, 1239-1246. Roca, J. (1995) The mechanisms of DNA topoisomerases. Trends Biochem Sci, 20, 156-160. Roca, J., Ishida, R., Berger, J.M., Andoh, T. and Wang, J.C. (1994) Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci U S A, 91, 1781-1785. Salti, G.I., Grewal, S., Mehta, R.R., Das Gupta, T.K., Boddie, A.W., Jr. and Constantinou, A.I. (2000) Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer, 36, 796-802. Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M. and Voipio-Pulkki, L.M. (1997) Apoptosis in human acute myocardial infarction. Circulation, 95, 320-323. Sehested, M. and Jensen, P.B. (1996) Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle. Biochem Pharmacol, 51, 879-886. Selzner, M., Rudiger, H.A., Selzner, N., Thomas, D.W., Sindram, D. and Clavien, P.A. (2002) Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion. J Hepatol, 36, 218-225. Siegmund, B., Schluter, K.D. and Piper, H.M. (1993) Calcium and the oxygen paradox. Cardiovasc Res, 27, 1778-1783. Siesjo, B.K., Katsura, K. and Kristian, T. (1996) Acidosis-related damage. Adv Neurol, 71, 209-233; discussion 234-206. Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 175, 184-191. Stanley, W.C. (2004) Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies. J Cardiovasc Pharmacol Ther, 9 Suppl 1, S31-45. Sullivan, D.M., Latham, M.D. and Ross, W.E. (1987) Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Cancer Res, 47, 3973-3979. Sundin, O. and Varshavsky, A. (1981) Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication. Cell, 25, 659-669. Tan, K.B., Dorman, T.E., Falls, K.M., Chung, T.D., Mirabelli, C.K., Crooke, S.T. and Mao, J. (1992) Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res, 52, 231-234. Tsai-Pflugfelder, M., Liu, L.F., Liu, A.A., Tewey, K.M., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C.M. and Wang, J.C. (1988) Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci U S A, 85, 7177-7181. Varga-Weisz, P.D., Wilm, M., Bonte, E., Dumas, K., Mann, M. and Becker, P.B. (1997) Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature, 388, 598-602. Wang, J.C. (1971) Interaction between DNA and an Escherichia coli protein omega. J Mol Biol, 55, 523-533. Wang, J.C. (1985) DNA topoisomerases: nature's solution to the topological ramifications of the double-helix structure of DNA. Harvey Lect, 81, 93-110. Wang, J.C. (1991) DNA topoisomerases: why so many? J Biol Chem, 266, 6659-6662. Wang, J.C. (1996) DNA topoisomerases. Annu Rev Biochem, 65, 635-692. Wang, J.C. (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol, 3, 430-440. Wang, J.C., Caron, P.R. and Kim, R.A. (1990) The role of DNA topoisomerases in recombination and genome stability: a double-edged sword? Cell, 62, 403-406. Wang, J.C. and Giaever, G.N. (1988) Action at a distance along a DNA. Science, 240, 300-304. Watanabe, M., Tsutsui, K., Tsutsui, K. and Inoue, Y. (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res, 19, 51-57. Watson, J.D. and Crick, F.H. (1953) Genetical implications of the structure of deoxyribonucleic acid. Nature, 171, 964-967. Watt, P.M. and Hickson, I.D. (1994) Structure and function of type II DNA topoisomerases. Biochem J, 303 ( Pt 3), 681-695. Welsh, F.A., Ginsberg, M.D., Rieder, W. and Budd, W.W. (1980) Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. II. Regional metabolite levels. Stroke, 11, 355-363. Woessner, R.D., Mattern, M.R., Mirabelli, C.K., Johnson, R.K. and Drake, F.H. (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ, 2, 209-214. Xiao, H., Li, T.K., Yang, J.M. and Liu, L.F. (2003) Acidic pH induces topoisomerase II-mediated DNA damage. Proc Natl Acad Sci U S A, 100, 5205-5210. Xu, L., Glassford, A.J., Giaccia, A.J. and Giffard, R.G. (1998) Acidosis reduces neuronal apoptosis. Neuroreport, 9, 875-879. Yang, X., Li, W., Prescott, E.D., Burden, S.J. and Wang, J.C. (2000) DNA topoisomerase IIbeta and neural development. Science, 287, 131-134. Yaoita, H., Ogawa, K., Maehara, K. and Maruyama, Y. (1998) Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation, 97, 276-281. Zechiedrich, E.L., Christiansen, K., Andersen, A.H., Westergaard, O. and Osheroff, N. (1989) Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate. Biochemistry, 28, 6229-6236. Zhou, N., Xiao, H., Li, T.K., Nur, E.K.A. and Liu, L.F. (2003) DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem, 278, 29532-29537. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33539 | - |
dc.description.abstract | 胞內酸化 (Intracellular acidification)被報導參與在器官局部缺血後再灌流 (ischemia/reperfusion) 所造成的器官傷害與細胞凋亡 (apoptosis)。之前研究也指出酸 (acidic pH) 可能造成DNA的損傷。然而,到目前為止,酸如何導致DNA的傷害以及酸化如何造成細胞死亡的分子機制還不清楚。在本篇論文中,我們利用細胞暴露在酸性的培養液中去模擬生理上當心肌梗塞或是中風時所造成的酸化現象。我們目前的研究清楚指出酸能直接造成DNA的斷裂而使DNA受到損害。由溫度及螯化物的實驗結果可推測出酸所造成的DNA 斷裂是需要酵素參與在其中的。有趣的是,這些由酸導致DNA片段的形成是可逆的;並且能被第二型DNA拓樸酶 (TOP2) 的抑制劑,ICRF-193,給中和抵消。由這些實驗結果顯示,TOP2可能參與在酸所引起的DNA傷害之中。與上述觀察到的結果一致,相對於TOP2表現正常的細胞 (HL-60),在TOP2缺失的細胞 (HL-60/MX2) 中可看到由酸引起的DNA斷裂以及細胞死亡的現象明顯下降。另外,RNA干擾 (RNAi) 實驗結果顯示兩種hTOP2異構酶,hTOP2α和hTOP2β,在酸引起的DNA損傷及細胞死亡中分別扮演不同的角色。再者,不論是hTOP2α,hTOP2β RNAi-knockdown細胞株,或是TOP2β-/-剔除鼠胚胎纖維組織母細胞 (MEFs) 皆能抵抗由酸所造成的DNA傷害。總之,我們的研究結果推測出在ischemia發生時,hTOP2β可能在酸所引起的細胞凋亡及器官失能中扮演著重要的角色。我們也意外地觀察到較低的pH值會去抑制H9c2心肌細胞中由酸造成的DNA損害訊息的活化,因此對於在ischemia/reperfusion損害中所產生與pH相關的自相矛盾論點 (pH paradox) 提供了一個可能的解釋。 | zh_TW |
dc.description.abstract | Intracellular acidification has been associated with apoptosis which has been attributed to mediate ischemia/reperfusion injuries and studies have also suggested that acidic pH might cause DNA damage. However, the molecular mechanisms underlying acidic pH induced-DNA damage and acidotic apoptosis remain unclear. In this thesis, cellular exposure to extracellular acidic pH (pHe) media was employed to simulate acidosis during heart failure and stroke. The present study indicates that acidic pHe can cause DNA damage by inducing DNA breakage directly. Temperature and chelator experiments suggested that acidic pHe-induced DNA breakage is enzymatic. Interestingly, the formation of these acidic pHe-induce DNA breakages is reversible and can be antagonized by a specific topoisomerase II (TOP2) catalytic inhibitor, ICRF-193. These results highly suggested the potential involvement of TOP2 in acidic pH induced-DNA damage. In agreement with above notion, hTOP2-deficient HL-60/MX2 cells, compared to parental HL-60 cells, exhibited a reduction in DNA breakage and apoptosis induced by acidic pHe. The differential role of hTOP2 isozymes, hTOP2a and hTOP2b, in acidic pH induced-DNA damage and apoptosis was revealed using RNA interference (RNAi)-specific knockdown cell lines. Either hTOP2a or 2b knockdown cell lines and TOP2b-/- knockout mouse embryo fibroblasts (MEFs) were resistant to acidic pH-induced DNA breakage. In sum, our study suggested that hTOP2b might play a more important role in acidotic apoptosis during ischemia. Unexpectedly, we have also observed that lower acidic pH inhibit DNA damage signaling and apoptotic pathways in H9c2 cardiomyocytes, thereby providing a potential explanation for the pH paradox in ischemia/reperfusion injuries. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:46:11Z (GMT). No. of bitstreams: 1 ntu-95-R93445127-1.pdf: 3900916 bytes, checksum: 82dfd9e4319bc9b82676abcb863e3216 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 中文摘要……………………………………………………………1
ABSTRACT……………………………………………………………2 INTRODUCTION………………………………………………………3 1. Ischemia 1-1. Pathophysiological states related to ischemia 1-2. Ischemic cascade 1-3. Acidosis during ischemia 2. Acidosis 2-1. The underlying mechanisms for acidic pH-mediated cell-killing 2-1-1. Exposure of acidic pH induces DNA damage in cells 2-1-2. Potential underlying mechanism(s) for acidosis-induced apoptotic cell death 2-2. Acidosis also correlated with increment or reduction of apoptosis cell death during ischemia 2-3. Ischemia/reperfusion triggers apoptosis and pH paradox 3. DNA topoisomerases 3-1. The mechanisms of Type I and Type II topoisomerases 3-2. Catalytic cycle and structure of Type II alpha and beta (TOP2a and TOP2b) 3-3. Function and cell cycle regulation of two TOP2 isozymes: 2a and 2b 4. TOP2-targeting conditions and cell death 4-1. Poisons and catalytic inhibitors of hTOP2 4-2. Physiological poisoning conditions for TOP2 4-3. Properties of TOP2-DNA cleavable complexes SPECIFIC AIMS………………………………………………………15 MATERIALS AND METHODS……………………………………………16 - Chemicals, and cell culture - TOP2-mediated DNA cleavage assay in vitro - Comet assay (Alkaline Single Cell Gel Electrophoresis assay) - Statistic analysis - Pulsed-Field Gel Electrophoresis (PFGE) analysis - Antibodies and western blot analysis - Nucleosomal DNA fragmentation assay (apoptotic assay) RESULTS………………………………………………………………21 - Cellular exposure to acidic pHe induces single-DNA breakage evidenced by comet assay - Cellular exposure to acidic pHe induces double-DNA breakage as evidenced by PFGE analysis - Induction of DNA breakage by acidic pHe is time-dependent manner - Acidic pHe-induced DNA fragmentation is enzymatic - DNA strand breakage induced by acidic pHe were protein-linked and reversible - Acidic pHe-induced DNA fragmentation and apoptosis can antagonized by ICRF-193 - Acidic pHe-induced DNA breakage and apoptosis was reduced in TOP2-deficient conditions - Acidic pHe traps reversible TOP2 cleavable complex in vitro - Both isozymes contribute to acidic pHe-induced DNA cleavage - Mouse TOP2b contributes to both acidic pHe-induced DNA breakage and apoptosis - Signaling molecules involved in either DNA damage responses or apoptotic cell death pathways can be either activated or repressed by acidic pH depending on acidity DISCUSSIONS…………………………………………………………30 - The potential physiological role(s) of TOP2-mediated DNA breakage induced by acidic pH - The TOP2 catalytic inhibitors as potential cardioprotective agents during ischemic conditions - Acidic pH paradox during ischemia FIGURES………………………………………………………………34 - Figure 1 Catalytic cycle of DNA topoisomerase II (TOP2) and potential action sites for TOP2-targeting poisons and inhibitors - Figure 2 Treatment with different pHe media induces DNA breakage - Figure 3 Quantification results of Figure 2 - Figure 4 Cellular exposure to acidic pHe media induce DNA double-stranded breaks - Figure 5 Acidic pHe-induced DNA breakage is time-dependent - Figure 6 Quantification results of Figure 5 - Figure 7 The formation of acidic pHe-induced DNA double-stranded breaks is also time-dependent as revealed by the PFGE analysis - Figure 8 Enzymatic dependence of acidic pHe-induced DNA fragmentation - Figure 9 The formation of acidic pHe-induced DNA breakage is reversible - Figure 10 Quantification results of Figure 9 - Figure 11 ICRF-193 specifically antagonizes pHe-induced DNA fragmentation - Figure 12 Quantification results of Figure 11 - Figure 13 Induction of DNA breakage by acidic pHe is reduced in a TOP2-deficient cell lines - Figure 14 Quantification results of Figure 13 - Figure 15 Acidic pHe-induced DNA breakage is reduced in the RNAi-mediated specific TOP2a-knockdown cell line - Figure 16 Quantification results of Figure 15 - Figure 17 The formation of acidic pHe-induced DNA breakage is reduced in the RNAi-mediated specific TOP2b-knockdown cell line - Figure 18 Quantification results of Figure 17 - Figure 19 Both TOP2 isozymes contribute to DNA fragmentation induced by acidic pHe media - Figure 20 Acidic pHe-induced DNA breakage was reduced in TOP2 (-/-) mouse embryo fibroblasts (MEFs) - Figure 21 Quantification results of Figure 20 - Figure 22 Acidic pH-mediated activation or inhibition of DNA damage signaling APPENDIXES……………………………………………………………57 - Appendix Figure 1 ICRF-193 antagonizes acidic pHe-induced apoptosis - Appendix Figure 2 Reduction of acidic pHe-induced nucleosomal DNA fragmentation in a TOP2-deficient cell line - Appendix Figure 3 Acidic pHe induces reversible DNA breakage in the presence of hTOP2a or hTOP2b in vitro - Appendix Figure 4 Western blot analysis demonstrated the knockdown efficiencies of TOP2-targeting siRNA-containing plasmids in HCT116 cells - Appendix Figure 5 Acidic pHe-induced apoptosis is reduced in TOP2b-/- mouse embryo fibroblasts (MEFs) REFERENCES……………………………………………………………63 | |
dc.language.iso | en | |
dc.title | 探討人類第二型拓樸酶在酸造成的DNA斷裂中所扮演之角色 | zh_TW |
dc.title | Contribution of human topoisomerase II to acidic pH-induced DNA breakage | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳瑞華,鄧述諄 | |
dc.subject.keyword | 第二型拓樸酶,酸化現象,DNA斷裂, | zh_TW |
dc.subject.keyword | topoisomerase II,acidosis,DNA breakage, | en |
dc.relation.page | 70 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-18 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 3.81 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。